A combination of silybin and carvedilol for treating liver fibrosis is more effective than either drug alone. | Drug ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together produces a much stronger effect than using either one alone, suggesting a ...

The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially ...

November 17, 2006 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise on the use of carvedilol tablets in diabetic patients; the risk for potentially fatal ...

The Supreme Court declined to hear Teva's challenge to a $235 million award to GlaxoSmithKline in a patent dispute over generic drugs involving heart medication Coreg, according to a Reuters report.

The U.S. Food and Drug Administration today approved the first generic versions of Coreg (carvedilol). Coreg is a widely used medication that is FDA-approved to treat high blood pressure, mild to ...

NEW YORK Teva has settled a case against Dr. Reddy’s concerning its patent on carvedilol, the active ingredient in GlaxoSmithKline’s heart drug Coreg. Teva started filing suits last June to protect ...